Drugs.com - Clinical Trials

AI Screening for Opioid Use Disorder Associated with Fewer Hospital Readmissions

April 3, 2025 -- An artificial intelligence (AI)-driven screening tool, developed by a National Institutes of Health (NIH)-funded research team, successfully identified hospitalized adults at risk for opioid use disorder and recommended referral to...

May 12, 2025 - 09:53
 0
AI Screening for Opioid Use Disorder Associated with Fewer Hospital Readmissions
April 3, 2025 -- An artificial intelligence (AI)-driven screening tool, developed by a National Institutes of Health (NIH)-funded research team, successfully identified hospitalized adults at risk for opioid use disorder and recommended referral to...
Read More

Tags:

Previous Article

Vividion Therapeutics Doses First Patient in Phase I Study of RAS-PI3Kα Inhibito...

Next Article

Biogen’s Investigational Tau-Targeting Therapy BIIB080 Receives FDA Fast Track D...

Related Posts

BlueRock Therapeutics Announces Publication in Nature of 18-Month Data from Phase 1 Clinical Trial for Bemdaneprocel, an Investigational Cell Therapy for Parkinson’s Disease

BlueRock Therapeutics Announces Publication in Nature o...

May 12, 2025  0

FDA Accepts Filing Application for Oral Semaglutide 25 mg, Which If Approved, Would Be The First Oral GLP-1 Treatment for Obesity

FDA Accepts Filing Application for Oral Semaglutide 25 ...

May 12, 2025  0

Novo Nordisk Warns Consumers About Counterfeit Ozempic (semaglutide) Injection 1 mg in the US

Novo Nordisk Warns Consumers About Counterfeit Ozempic ...

May 12, 2025  0